Comprehensive treatment of unresectable cardiac angiosarcoma: A case report and review of literature

Wang,Chao; Shi,Min; Yang,Chen; Ma,Tao; Jiang,Jinling; Liu,Ying; Xi,Wenqi; Zhu,Zhenggang; Zhang,Jun

doi:10.3892/mco.2017.1390

Comprehensive treatment of unresectable cardiac angiosarcoma: A case report and review of literature

Authors:
- Chao Wang
- Min Shi
- Chen Yang
- Tao Ma
- Jinling Jiang
- Ying Liu
- Wenqi Xi
- Zhenggang Zhu
- Jun Zhang
View Affiliations

Affiliations: Department of Oncology, Shanghai Key Laboratory of Gastric Neoplasms, Shanghai Institute of Digestive Surgery, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, P.R. China
Published online on: August 24, 2017 https://doi.org/10.3892/mco.2017.1390
Pages: 859-863

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Cardiac angiosarcoma is a rare but lethal tumor that is difficult to diagnose and treat, due to its rapid local relapse and high incidence of systemic metastasis. The prognosis of cardiac angiosarcoma is dismal, with a mean life expectancy of only a few months. We herein report a case of unresectable angiosarcoma arising from the right atrium. The patient received first‑line chemotherapy with weekly paclitaxel, and second‑line therapy with vinorelbine and bevacizumab upon disease progression. The progression‑free survival was 6 months and the overall survival was 7 months. The patient eventually succumbed to respiratory failure. A study of the present case and a review of the relevant literature suggest that treatment decisions for unresectable locally advanced or metastatic cardiac angiosarcoma are difficult, as the published literature on this disease mainly consists of case reports without sufficient data. Therefore, further clinical trials specific to the treatment of unresectable cardiac angiosarcoma are warranted.

View Figures

View References

1	Kurian KC, Weisshaar D, Parekh H, Berry GJ and Reitz B: Primary cardiac angiosarcoma: Case report and review of the literature. Cardiovasc Pathol. 15:110–112. 2006. View Article : Google Scholar : PubMed/NCBI
2	Kupsky DF, Newman DB, Kumar G, Maleszewski JJ, Edwards WD and Klarich KW: Echocardiographic features of cardiac angiosarcomas: The mayo clinic experience (1976–2013). Echocardiography. 33:186–192. 2016. View Article : Google Scholar : PubMed/NCBI
3	Araoz PA, Eklund HE, Welch TJ and Breen JF: CT and MR imaging of primary cardiac malignancies. Radiographics. 19:1421–1434. 1999. View Article : Google Scholar : PubMed/NCBI
4	Young RJ, Brown NJ, Reed MW, Hughes D and Woll PJ: Angiosarcoma. Lancet Oncol. 11:983–991. 2010. View Article : Google Scholar : PubMed/NCBI
5	Prabu Ram MP, Thulkar S, Ray R and Bakhshi S: Primary cardiac angiosarcoma with good response to Paclitaxel. J Thorac Oncol. 6:1778–1779. 2011. View Article : Google Scholar : PubMed/NCBI
6	Pigott C, Welker M, Khosla P and Higgins RS: Improved outcome with multimodality therapy in primary cardiac angiosarcoma. Nat Clin Pract Oncol. 5:112–115. 2008. View Article : Google Scholar : PubMed/NCBI
7	Suderman D, Cooke A, Wong R and Klein J: Treatment of cardiac angiosarcoma with radiation and docetaxel: A case report with partial response and prolonged stable disease. J Thorac Oncol. 6:834–835. 2011. View Article : Google Scholar : PubMed/NCBI
8	Kodali D and Seetharaman K: Primary cardiac angiosarcoma. Sarcoma. 2006:391302006. View Article : Google Scholar : PubMed/NCBI
9	Hata A, Katakami N, Fujita S, Kokubo M and Imai Y: Angiosarcoma arising from right atrium: Remarkable response to concurrent chemoradiotherapy with carboplatin and paclitaxel. J Thorac Oncol. 6:970–971. 2011. View Article : Google Scholar : PubMed/NCBI
10	Franceschini D, Scotti V, Simontacchi G, Meattini I, Paiar F, Greto D, Bonomo P, Franzese C, Di Cataldo V, Pallotta S and Biti G: Application of helical tomotherapy for the treatment of a right atrium angiosarcoma: A case report. Tumori. 99:e233–e236. 2013.PubMed/NCBI
11	Fehr M, Kuhn M, Mayer K, Padberg B, Ulmer U and Cathomas R: Metastatic angiosarcoma arising from the right atrium: Unusual presentation and excellent response to treatment in a young patient. J Thorac Oncol. 5:1301–1302. 2010. View Article : Google Scholar : PubMed/NCBI
12	Castilla E, Pascual I, Roncalés F, Aguirre E and Del Río A: Transient response of cardiac angiosarcoma to paclitaxel. Eur J Cancer Care (Engl). 19:699–700. 2010. View Article : Google Scholar : PubMed/NCBI
13	Batzios S, Michalopoulos A, Kaklamanis L, Stathopoulos J, Christopoulou M, Koutantos J and Stathopoulos GP: Angiosarcoma of the heart: Case report and review of the literature. Anticancer Res. 26:4837–4842. 2006.PubMed/NCBI
14	Aoka Y, Kamada T, Kawana M, Yamada Y, Nishikawa T, Kasanuki H and Tsujii H: Primary cardiac angiosarcoma treated with carbon-ion radiotherapy. Lancet Oncol. 5:636–638. 2004. View Article : Google Scholar : PubMed/NCBI
15	Elsayad K, Lehrich P, Yppaerilae-Wolters H, Dieckmann C, Kriz J, Haverkamp U and Eich HT: Primary cardiac angiosarcoma treated with positron emission tomography/magnetic resonance imaging-guided adaptive radiotherapy. Can J Cardiol. 32:829.e7–829.e10. 2016. View Article : Google Scholar
16	Elsayad K, Scobioala S, Kriz J, Haverkamp U and Eich HT: Advances in image-guided radiation therapy for primary cardiac angiosarcoma: The role of PET-CT and MRI. Oncol Res Treat. 39:290–294. 2016. View Article : Google Scholar : PubMed/NCBI
17	Penel N, Bui BN, Bay JO, Cupissol D, Ray-Coquard I, Piperno-Neumann S, Kerbrat P, Fournier C, Taieb S, Jimenez M, et al: Phase II trial of weekly paclitaxel for unresectable angiosarcoma: The ANGIOTAX study. J Clin Oncol. 26:5269–5274. 2008. View Article : Google Scholar : PubMed/NCBI
18	Anderson SE, Keohan ML, D'Adamo DR and Maki RG: A retrospective analysis of vinorelbine chemotherapy for patients with previously treated soft-tissue sarcomas. Sarcoma. 2006:159472006. View Article : Google Scholar : PubMed/NCBI
19	Dileo P, Morgan JA, Zahrieh D, Desai J, Salesi JM, Harmon DC, Quigley MT, Polson K, Demetri GD and George S: Gemcitabine and vinorelbine combination chemotherapy for patients with advanced soft tissue sarcomas: Results of a phase II trial. Cancer. 109:1863–1869. 2007. View Article : Google Scholar : PubMed/NCBI
20	Agulnik M, Yarber JL, Okuno SH, von Mehren M, Jovanovic BD, Brockstein BE, Evens AM and Benjamin RS: An open-label, multicenter, phase II study of bevacizumab for the treatment of angiosarcoma and epithelioid hemangioendotheliomas. Ann Oncol. 24:257–263. 2013. View Article : Google Scholar : PubMed/NCBI
21	Yang P, Zhu Q and Jiang F: Combination therapy for scalp angiosarcoma using bevacizumab and chemotherapy: A case report and review of literature. Chin J Cancer Res. 25:358–361. 2013.PubMed/NCBI
22	De Yao JT, Sun D, Powell AT and Rehmus EH: Scalp angiosarcoma remission with bevacizumab and radiotherapy without surgery: A case report and review of the literature. Sarcoma. 2011:1603692011. View Article : Google Scholar : PubMed/NCBI
23	Koontz BF, Miles EF, Rubio MA, Madden JF, Fisher SR, Scher RL and Brizel DM: Preoperative radiotherapy and bevacizumab for angiosarcoma of the head and neck: Two case studies. Head Neck. 30:262–266. 2008. View Article : Google Scholar : PubMed/NCBI
24	Jeng MR, Fuh B, Blatt J, Gupta A, Merrow AC, Hammill A and Adams D: Malignant transformation of infantile hemangioma to angiosarcoma: Response to chemotherapy with bevacizumab. Pediatr Blood Cancer. 61:2115–2117. 2014. View Article : Google Scholar : PubMed/NCBI
25	Nespereira-Jato MV, Peña-Panabad C, Quindós-Varela M and García-Silva J: Unresectable angiosarcoma treated with bevacizumab and paclitaxel. Actas Dermosifiliogr. 105:520–522. 2014. View Article : Google Scholar : PubMed/NCBI
26	van der Graaf WT, Blay JY, Chawla SP, Kim DW, Bui-Nguyen B, Casali PG, Schöffski P, Aglietta M, Staddon AP, Beppu Y, et al: Pazopanib for metastatic soft-tissue sarcoma (PALETTE): A randomised, double-blind, placebo-controlled phase 3 trial. Lancet. 379:1879–1886. 2012. View Article : Google Scholar : PubMed/NCBI